CONTTRIBUTE

Welcome to the Brand page for “CONTTRIBUTE”, which is offered here for Contribute;maintaining a clinical registry database for patients with mutations of the transthyretin gene; maintaining a registry on the clinical outcomes of attr amyloidosis in patients over time;.

Its status is currently believed to be active. Its class is unavailable. “CONTTRIBUTE” is believed to be currently owned by “Alnylam Pharmaceuticals, Inc.”


Owner:
ALNYLAM PHARMACEUTICALS, INC.
Owner Details
Description:
CONTRIBUTE;Maintaining a clinical registry database for patients with mutations of the transthyretin gene; maintaining a registry on the clinical outcomes of ATTR amyloidosis in patients over time;
Categories: CONTRIBUTE